iA Global Asset Management’s CG Oncology CGON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-48,660
Closed -$1.96M 409
2025
Q3
$1.96M Buy
48,660
+4,260
+10% +$124K 0.03% 264
2025
Q2
$1.15M Sell
44,400
-1,150
-3% -$27.7K 0.02% 271
2025
Q1
$1.12M Sell
45,550
-340
-0.7% -$9.56K 0.02% 300
2024
Q4
$1.32M Buy
+45,890
New +$1.57M 0.02% 278

Other funds holding CGON

iA Global Asset Management's CGON Position: Q4 2025 in Review

iA Global Asset Management sold out of CG Oncology (CGON) in Q4 2025, closing a stake of 48,660 shares — an estimated $1.96M sold.

iA Global Asset Management first reported a position in CGON in Q4 2024 and held it in 4 quarters. The position peaked at $1.96M in Q3 2025. 195 funds tracked by Wall St. Rank hold CGON as of Q4 2025.

  • iA Global Asset Management reported no remaining CG Oncology position as of Q4 2025 after selling out during the quarter.
  • iA Global Asset Management sold 48,660 CG Oncology shares in Q4 2025, an estimated $1.96M.
  • iA Global Asset Management first reported a position in CG Oncology in Q4 2024 and held it in 4 quarters.
  • iA Global Asset Management's CG Oncology position peaked at $1.96M in Q3 2025.
  • 195 funds tracked by Wall St. Rank held CG Oncology as of Q4 2025.

Based on iA Global Asset Management's 13F filing for Q4 2025, filed 5 Feb 2026.